Cagrilintide

Cagrilintide is a synthetic, lipidated analogue of the pancreatic hormone amylin, engineered with backbone substitutions and a fatty-diacid side chain that reduce fibril formation and extend its presence in circulation relative to native amylin. Structurally it retains the intramolecular disulfide loop characteristic of the amylin/calcitonin peptide family, and it is described in the primary literature as a nonselective agonist across amylin and calcitonin receptor subtypes.

In preclinical research it is used as a tool compound to probe how sustained amylin-receptor signaling shapes food-intake behavior, gastric-emptying dynamics, and glucose handling in cell and animal models. Because it engages the same receptor family as native amylin while resisting aggregation, investigators use it to separate long-acting receptor pharmacology from the assay artifacts that complicate work with the native peptide. Its behavior in combination with incretin-pathway agonists is an active area of comparative study; those observations are preclinical and should not be read as established human pharmacology.

BioTech Pharma supplies cagrilintide as a lyophilized powder for laboratory research use only. Lot-specific analytical documentation may be available and should be confirmed for the applicable material. Bulk and custom-fill quantities are available on a quote basis for institutional programs.